GlassScriptPhysician profile
Christa Anne Hoffeditz
NPI 1528050317
$2,383.16
in general payments reported to CMS, 2019-2025
18 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $645 · 2022: $447 · 2023: $506 · 2024: $447 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,290.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $428.23 | 2022-2024 | Optimizer, Optimizer |
| E.R. Squibb & Sons, L.L.C. | $372.11 | 2021-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $252.18 | 2021 | |
| Boston Scientific Corporation | $240.27 | 2022-2025 | Avvigo Guidance System, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $218.66 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $203.77 | 2021-2024 | Xarelto |
| Medtronic, INC. | $200.71 | 2021-2025 | Selectsite, Cobalt Dr Mri Surescan |
| Actelion Pharmaceuticals US, INC. | $84.27 | 2022-2025 | Uptravi, Opsumit |
| Daiichi Sankyo INC. | $76.47 | 2023-2024 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.62 | 2022 | |
| Novartis Pharmaceuticals Corporation | $42.82 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $39.70 | 2022 | |
| Amgen INC. | $37.39 | 2023 | Repatha |
| Kestra Medical Technology Services, INC. | $34.10 | 2025 | Assure Wcd |
| Chiesi USA, INC. | $32.26 | 2022-2025 | Cleviprex, Kengreal |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $32.08 | 2025 | |
| Sanofi-Aventis U.S. LLC | $21.87 | 2022 | |
| Janssen Scientific Affairs, LLC | $20.65 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christa Hoffeditz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.